Compare Revvity Inc (RVTY) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs 22nd Century Group Inc — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Revvity Inc is far larger — about 7966.4× 22nd Century Group Inc's market cap, and Revvity Inc pays a 0.26% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| RVTY | XXII | |
|---|---|---|
Market Cap | $11.87B | $1.49M |
Sector | Technology | Technology |
52-Week High | $117.75 | $1.07K |
52-Week Low | $82.26 | $3.90 |
Enterprise Value | $14.36B | -$6.74M |
Dividend Yield | 0.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
